The purpose of this study is to define the standard use of TCM treatment regimen as the TCM cohort group and the non-TCM cohort group of those who use conventional Western medicine treatment without the standard TCM treatment regimen through a multi-center, large-sample prospective cohort study design. To evaluate the clinical efficacy and safety of TCM treatment regimens in the treatment of bronchial asthma, and to provide high-quality evidence for the promotion and application of TCM syndrome differentiation treatment in bronchial asthma.
Patients who meet the diagnosis of bronchial asthma;
Age 18~80 years old;
Have not participated in other clinical studies within 1 month before enrollment;
Voluntarily participate in the study and sign the informed consent form.
Patients with respiratory failure and mechanical ventilation during acute asthma exacerbation;
Delirium, impaired consciousness, dementia, and various mental illnesses;
Patients with other lung diseases such as COPD, lung abscess, cystic fibrosis, bronchiectasis, etc., and severe liver and kidney diseases;
Patients with neuromuscular diseases that affect respiratory motor function and are unable to complete the six-minute walk test;
Henan University of Traditional Chinese Medicine
Lead sponsor
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Collaborator
Tianjin University of Traditional Chinese Medicine
Collaborator
Third Affiliated Hospital of Henan University of Traditional Chinese Medicine
Collaborator
Hebei Provincial Hospital of Traditional Chinese Medicine
Collaborator
Peking University People's Hospital
Collaborator
The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Collaborator
The First Affiliated Hospital of Zhengzhou University
Collaborator
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Collaborator
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Collaborator